Cargando…
Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer
BACKGROUND: The spatial distribution of tumor-infiltrating T cells and its dynamics during chemoradiotherapy combined with PD-1 blockade is little known in esophageal squamous cell carcinoma (ESCC). METHODS: We applied the multiplex immunofluorescence method to identify T cells (CD4(+), CD8(+) T cel...
Autores principales: | Yan, Cihui, Huang, Hui, Zheng, Zhunhao, Ma, Xiaoxue, Zhao, Gang, Zhang, Tian, Chen, Xi, Cao, Fuliang, Wei, Hui, Dong, Jie, Tang, Peng, Jiang, Hongjing, Wang, Meng, Wang, Ping, Pang, Qingsong, Zhang, Wencheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235618/ https://www.ncbi.nlm.nih.gov/pubmed/37275884 http://dx.doi.org/10.3389/fimmu.2023.1138054 |
Ejemplares similares
-
Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade
por: Ma, Xiaoxue, et al.
Publicado: (2022) -
Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade
por: Yan, Cihui, et al.
Publicado: (2022) -
Comparison of dynamic changes in the peripheral CD8(+) T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy
por: Wei, Hui, et al.
Publicado: (2022) -
Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019) -
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
por: Zhang, Tian, et al.
Publicado: (2022)